Search Results - "BESSES, CARLES"
-
1
Effect of Mutation Order on Myeloproliferative Neoplasms
Published in The New England journal of medicine (12-02-2015)“…About 10% of myeloproliferative neoplasms carry mutations in both TET2 and JAK2 . Clinical presentation, risk of thrombosis, and rates of tumor progression are…”
Get full text
Journal Article -
2
Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera
Published in Blood (09-02-2012)“…Criteria of response and definition of resistance and intolerance to hydroxyurea (HU) in polycythemia vera (PV) were proposed by the European LeukemiaNet…”
Get full text
Journal Article -
3
Hematological disorders: a commonly unrecognized cause of acute stroke
Published in Expert review of hematology (01-09-2016)“…Hematological disorders account for about 1.3% of all causes of acute stroke. This systematized review presents updated information on the implications of this…”
Get more information
Journal Article -
4
Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated
Published in Haematologica (Roma) (01-08-2019)“…In this study we interrogated the DNA methylome of myelofibrosis patients using high-density DNA methylation arrays. We detected 35,215 differentially…”
Get full text
Journal Article -
5
-
6
Clinical evaluation of the European LeukaemiaNet criteria for clinicohaematological response and resistance/intolerance to hydroxycarbamide in essential thrombocythaemia
Published in British journal of haematology (01-01-2011)“…Summary Standardized criteria of response to treatment and a unified definition of resistance/intolerance to hydroxycarbamide (HC) in essential…”
Get full text
Journal Article -
7
Pemphigus‐like hypereosinophilic syndrome with FIP1L1–PDGFRA fusion gene: A challenging and uncommon clinical presentation
Published in Journal of dermatology (01-06-2019)“…Hypereosinophilic syndrome (HES) is often associated with cutaneous manifestations, mostly pruritic lesions, urticaria and angioedema. Mucosal lesions are…”
Get full text
Journal Article -
8
Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome
Published in PloS one (19-12-2012)“…FOXP3+ regulatory T cells (Treg) play an essential role in modulating host responses to tumors and infections. The role of these cells in the pathogenesis of…”
Get full text
Journal Article -
9
Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms
Published in Haematologica (Roma) (01-09-2013)“…Most DNA methylation studies in classic Philadelphia-negative myeloproliferative neoplasms have been performed on a gene-by-gene basis. Therefore, a more…”
Get full text
Journal Article -
10
A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera
Published in Blood (31-05-2012)“…Patients with essential thrombocythemia (ET) and polycythemia vera (PV) have an increased incidence of acute myeloid leukemia and new nonhematologic…”
Get full text
Journal Article -
11
Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib
Published in Annals of dermatology (01-04-2019)“…Ruxolitinib is a Janus kinase (JAK)1 and JAK2 inhibitor approved for the treatment of myelofibrosis and for polycythemia patients who are resistant or…”
Get full text
Journal Article -
12
JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis
Published in Haematologica (Roma) (01-12-2007)“…* Departments of Pathology and ° Clinical Hematology Hospital del Mar, IMAS, Barcelona; # Department of Hematology, Hospital Clínic, University of Barcelona; @…”
Get full text
Journal Article -
13
FISH is better than BIOMED-2 PCR to detect IgH/ BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections
Published in Leukemia research (01-05-2008)“…The most common genetic aberration in follicular lymphoma (FL) is the t(14;18)(q32;q21) translocation that juxtaposes the antiapoptotic BCL2 gene with the…”
Get full text
Journal Article -
14
Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells
Published in Leukemia & lymphoma (03-03-2016)“…Current standard-of-care therapy for diffuse large B-cell lymphoma (DLBCL) results in up to 40% of patients who either relapse or develop refractory disease…”
Get full text
Journal Article -
15
Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasms
Published in Leukemia research (01-09-2016)“…•CALR-mutated ET patients harbored a higher mutant load at progenitor level than JAK2-positive ET.•Hematopoietic stem cells of CALR-mutated ET showed a similar…”
Get full text
Journal Article -
16
Primary epidural lymphoma
Published in Journal of neurosurgery (01-03-2003)Get full text
Journal Article -
17
The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia
Published in Cancer cell (14-09-2010)“…It was previously shown that the NF-κB pathway is downstream of oncogenic Notch1 in T cell acute lymphoblastic leukemia (T-ALL). Here, we visualize…”
Get full text
Journal Article -
18
Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up
Published in Annals of hematology (01-03-2018)“…JAK2 V617F monitoring and NGS of non-driver genes was performed in 100 patients with polycythemia vera (PV) or essential thrombocythemia (ET) with long…”
Get full text
Journal Article -
19
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
Published in Blood (10-03-2011)“…Although approximately 95% of patients with polycythemia vera (PV) harbor the V617F mutation in JAK2 exon 14, several mutations in exon 12 have been described…”
Get full text
Journal Article -
20
Clonal Dynamics of JAK2V617F and Non-Driver Mutations in Polycythemia Vera and Essential Thrombocythemia Patients Receiving Hydroxyurea Therapy
Published in Blood (23-11-2021)“…▪ Introduction: Hydroxyurea (HU) is the most widely used cytoreductive treatment for patients with essential thrombocythemia (ET) and polycythemia vera (PV) at…”
Get full text
Journal Article